Endothelial‐Mesenchymal Transition in Tumor Microenvironment Promotes Neuroendocrine Differentiation of Prostate Cancer
Cancer Science · 2025-10 · 116 (10) · 2712-2722
DOI: 10.1111/cas.70144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 24.07.2025. Verfasst von Takumi Kageyama und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Tsu, Japan. Hauptthemen laut MEDLINE: Tumor Microenvironment, Prostatic Neoplasms, Castration-Resistant, Prostatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Neuroendocrine prostate cancer (NEPC) is a highly aggressive and treatment‐resistant subtype of castration‐resistant prostate cancer (CRPC) that often emerges during progression under androgen‐receptor (AR) pathway inhibition. While lineage plasticity in cancer cells has been recognized as a key mechanism of resistance, the role of the tumor microenvironment in driving this transition remains unclear. Among its cellular components, vascular endothelial cells can undergo endothelial‐mesenchymal transition (EndoMT), a phenotypic shift associated with tumor progression and fibrosis. Here, we investigated whether EndoMT contributes to NEPC development. Human umbilical vein endothelial cells (HUVEC) were induced to undergo EndoMT using IL‐1β and TGF‐β2, and are hereafter referred to as EndoMTed HUVEC. EndoMTed HUVEC promoted neuroendocrine features and functional changes in LNCaP cells. Transcriptome analysis revealed marked upregulation of granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) in EndoMTed HUVEC. Neutralization of GM‐CSF signaling using mavrilimumab, a monoclonal antibody targeting the GM‐CSF receptor alpha (CSF2RA), and siRNA‐mediated CSF2RA knockdown both suppressed the neuroendocrine phenotype and STAT3 signaling of LNCaP cells. Conversely, GM‐CSF stimulation alone reproduced these changes. Enzalutamide‐treated LNCaP cells secreted IL‐1β and TGF‐β2, which in turn triggered EndoMT, suggesting a reciprocal loop. These findings indicate that anti‐androgen therapy may inadvertently promote NEPC through a paracrine loop involving tumor‐derived cytokines and endothelial GM‐CSF secretion, highlighting EndoMT as a microenvironmental driver of treatment resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Tsu, Japan.
- Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan.
- Department of Oncologic Pathology, Mie University Graduate School of Medicine, Tsu, Japan.
ORCID-Profile: Takumi Kageyama, Takahiro Inoue
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Kageyama, T., Kato, M., Miyachi, S., Bao, X., Sekito, S., Sugino, Y., Higashi, S., Sasaki, T., Nishikawa, K., Murakawa, Y., Watanabe, M., & Inoue, T. (2025). Endothelial‐Mesenchymal Transition in Tumor Microenvironment Promotes Neuroendocrine Differentiation of Prostate Cancer. Cancer Science, 116(10), 2712-2722. https://doi.org/10.1111/cas.70144
Vancouver
Kageyama T, Kato M, Miyachi S, Bao X, Sekito S, Sugino Y, et al. Endothelial‐Mesenchymal Transition in Tumor Microenvironment Promotes Neuroendocrine Differentiation of Prostate Cancer. Cancer Science. 2025;116(10):2712-2722. doi:10.1111/cas.70144
BibTeX
@article{Kageyama2025,
author = {Kageyama, Takumi and Kato, Manabu and Miyachi, Shiori and Bao, Xin and Sekito, Sho and Sugino, Yusuke and Higashi, Shinichiro and Sasaki, Takeshi and Nishikawa, Kouhei and Murakawa, Yasuhiro and Watanabe, Masatoshi and Inoue, Takahiro},
title = {Endothelial‐Mesenchymal Transition in Tumor Microenvironment Promotes Neuroendocrine Differentiation of Prostate Cancer},
journal = {Cancer Science},
year = {2025},
volume = {116},
number = {10},
pages = {2712--2722},
doi = {10.1111/cas.70144}
}
EUVIMED